OBIO Announces National Call to Canadian Health Science Companies for Applications for the 2020 Niagara Investment Summit
July 18, 2019 – TORONTO, ONTARIO – The OBIO 2020 Niagara Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.
On February 5-7, 2020, the Summit will bring 30 of Canada’s most promising health science companies to Niagara-on-the-Lake to present to and meet with top-ranked global investors. The Summit will also feature keynote presentations from world-leading scientific and business experts.
“Building on the success of last year’s Summit, OBIO’s 2020 Niagara Investment Summit will bring the most innovative Canadian health science companies together with leading global investors to create opportunities for new and cross-border investments,” said Gail Garland, President and CEO, OBIO. “With world-class technologies, leading edge research and a great environment for investment, Canadian companies present an incredible opportunity for global health science investors. We are looking forward to bringing the world to Canada’s doorstep.”
The theme of the 2020 Niagara Investment Summit is the Future of Medicine. In company presentations & one-on-one meetings, the Summit will highlight Canada’s most investable health sciences companies across therapeutic, medical device, diagnostic & digital health sectors.
Presentation spots are limited. Companies interested in presenting to investors should submit an application at obioinvestmentsummit.com. Companies must include a non-confidential investor pitch deck, demonstrating the company’s investor readiness and fit within the theme of the Summit. Initial review of applications by an expert selection committee will begin August 8, 2019, and applicants will be notified of results by mid-September 2019. Applications submitted after August 8, 2019 will be reviewed on a rolling basis. Companies are encouraged to apply early, since presentation spots and travel awards are limited. Travel awards are only available to companies based outside of Ontario to defray travel costs.
Selected companies are responsible for the conference fee of $2,500 which includes:
Full registration for one company representative including two nights’ accommodation
An opportunity to pitch and hold one-on-one meetings with leading global investors
All meals for the duration of the conference
OBIO 2020 Niagara Investment Summit Eligibility
Companies with operations in Canada focused on developing health science products or services including but not limited to therapeutics, medical devices, diagnostics, or digital health which fit into the themes of the 2020 Niagara Investment Summit.
Companies with operations in Canada seeking to raise Series A and beyond investment.
About OBIO
The Ontario Bioscience Innovation Organization (OBIO®), a leading advocate for Canada’s health science industry, is a not-for-profit, membership-based organization engaged in the development of an integrated health innovation economy and one that will become a global leader in providing health technology products and services to the international marketplace. OBIO advances this goal through advocacy, promotion and strategic leadership and via collaborative partnerships with industry, academia, patients and government. For more information, visit www.obio.ca and follow OBIO on Twitter @OBIOscience